Cancer Research UK Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 26
  • Portfolio
  • 18
  • Exits
  • 9
Exits

Cancer Research UK General Information

Description

Cancer Research UK is an investment firm based in London, United Kingdom and was founded in 2002. The firm has exclusive rights of world-class cancer research annually. It offers unique opportunities to commercial partners looking for early involvement in new discoveries and is completely focused on cancer.

Contact Information

Formerly Known As
Cancer Research Technology
Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Angel Building
  • 407 Saint John Street
  • London EC1V 4AD
  • England, United Kingdom
+44 020 0000 0000

Cancer Research UK Investments (26)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Azeria Therapeutics 21-Nov-2019 Early Stage VC 000.00 Drug Discovery Startup
00000 000000000000 20-May-2019 00000 00000 000.00 Drug Discovery Generating Revenue
00000 00000 23-Apr-2019 0000 00000 Other Capital Markets/Institutions Generating Revenue
00000000 000000000 13-Sep-2017 00000 00000 000.00 Drug Discovery Clinical Trials - General
0000000000 000000 23-Aug-2017 00000 00000 000.00 Biotechnology Generating Revenue
00000000 20-Jun-2017 0000 00000 Drug Discovery Clinical Trials - Phase 1 000000 000000
000000 19-Sep-2016 00000 00000 0000 Drug Discovery Generating Revenue 000000 000000000 00.0
0000000000 0000000 15-Sep-2016 0000 00000 00.000 Biotechnology Generating Revenue 000 00000 00.0
Mission Therapeutics 02-Feb-2016 Later Stage VC 000.00 Drug Discovery Generating Revenue
BliNK Biomedical 11-Dec-2014 Early Stage VC 00.000 Biotechnology Generating Revenue
You’re viewing 10 of 26 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cancer Research UK Exits (8)

Company Name Exit Date Exit Type Exit Size
ADC Therapeutics 15-May-2020 IPO 00000
00000000 05-Feb-2019 000 00 00000000
00000 000000000000 01-Sep-2018 000000000000000000
00000000 01-Jul-2015 000000000000000000
00000 000000000000 28-Jan-2015 000000000000000000
0000000 000000 15-Apr-2008 000000000000000000 00000
KuDOS Pharmaceuticals 31-Jan-2006 Merger/Acquisition 00000
Chroma Therapeutics Out of Business
To view Cancer Research UK’s complete exits history, request access »

Cancer Research UK Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Cancer Research UK‘s full profile, request access.

Request a free trial

Cancer Research UK Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Cancer Research UK Team (15)

Name Title Deals Funds Boards Office
Iain Foulkes Ph.D Executive Director, Board Member & Chief Executive Officer, Cancer Research Technology London, United Kingdom
Michelle Mitchell Chief Executive Officer London, United Kingdom
Andrea Schievella Ph.D President, US Office Cambridge, MA
Tim Hammonds Ph.D Deputy Director of Drug Discovery London, United Kingdom
Stuart Farrow Director of Biology 0 0 0 Cambridge, MA
You’re viewing 5 of 15 team members. Get the full list »

Cancer Research UK Co-Investors (20)

Name With Exits Lead Partner Series Industry
M Ventures 3 0 Series chart Industry bar
Sixth Element Capital 0 0 Series chart Industry bar
Cambridge Innovation Capital 0 0 Series chart Industry bar
Syncona 0 0 Series chart Industry bar
IP Group 0 0 Series chart Industry bar
You’re viewing 5 of 20 co-investors. Get the full list »